Accelerated Pharma (Accelerated Pharma) COGS-to-Revenue : 0.00 (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma COGS-to-Revenue?

Accelerated Pharma's Cost of Goods Sold for the three months ended in Mar. 2017 was $0.00 Mil. Its Revenue for the three months ended in Mar. 2017 was $0.00 Mil.

Accelerated Pharma's COGS to Revenue for the three months ended in Mar. 2017 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Accelerated Pharma's Gross Margin % for the three months ended in Mar. 2017 was N/A%.

Accelerated Pharma COGS-to-Revenue Historical Data

The historical data trend for Accelerated Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma COGS-to-Revenue Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

COGS-to-Revenue

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
COGS-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma COGS-to-Revenue Calculation

Accelerated Pharma's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Accelerated Pharma's COGS to Revenue for the quarter that ended in Mar. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Accelerated Pharma (NAS:ACCP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Accelerated Pharma's Gross Margin % for the three months ended in Mar. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Accelerated Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines